BridgeMD
New treatment option for Calcitonin
Official title Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
ClinicalTrials.gov ID: NCT05805683
What this study is testing
What is Calcitonin?
Calcitonin is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for calcitonin.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This prospective randomized double blinded study will be conducted to evaluate the effect of early pharmacologic intervention with calcitonin on the incidence or the severity of neuropathic pain after spinal cord injury
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Patients aged ≥18 years, with spinal cord injury at any level and any degree of completeness in the early stage of trauma.
You likely can't join if
- Intake of anticonvulsants medications.
- Evidence of neuropathic pain.
- Evidence of previous allergic reaction to calcitonin.
- Patients with renal, hepatic and cardiac dysfunction or neurological disorders .
- brain damage or major trauma to extremities or abdomen.
The study team makes the final eligibility decision.
Where it's taking place
- Tanta, Gharbia Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tanta, Gharbia Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.